Butenafine Hydrochloride

CAS 101827-46-7 3 current recordsSmall Molecule

Who holds supplier records for Butenafine Hydrochloride? 3 organisations hold a current record for Butenafine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Italy (1), Japan (1) and Israel (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Butenafine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/butenafine-hydrochloride

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Butenafine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ERREGIERRE SPA
    Active DMF 18707 · latest filing Aug 2005
    Italy Company GMP cert on record
  • KAKEN Pharmaceutical Co., LTD
    Active DMF 11296 · latest filing Jan 1995
    Japan Company GMP cert on record
  • Taro Pharmaceutical Industries Ltd.
    Active DMF 19551 · latest filing Jun 2006
    Israel Company GMP cert on record
Need Butenafine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Butenafine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200397).

Chemical identity

IUPAC name
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine;hydrochloride
Canonical SMILES
CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl
InChIKey
LJBSAUIFGPSHCN-UHFFFAOYSA-N
Synonyms
Butenafine hcl, Butenafine hydrochloride, KP-363, Lotrimin ultra, Mentax, Mentax-tc, Volley, CHEBI:31325, Jock Itch Cream, Athletes Foot Ultra, Lotrimin Ultra Ringworm, RefChem:54582

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Benzylamine Antifungal
Chemical structure
Benzylamines

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Butenafine Hydrochloride?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Butenafine Hydrochloride: ERREGIERRE SPA (Italy), KAKEN Pharmaceutical Co., LTD (Japan) and Taro Pharmaceutical Industries Ltd. (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Butenafine Hydrochloride Drug Master Files are active?

ERREGIERRE SPA (DMF 18707), KAKEN Pharmaceutical Co., LTD (DMF 11296) and Taro Pharmaceutical Industries Ltd. (DMF 19551). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Butenafine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Butenafine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.